Identification of circulating CD31+CD45+ cell populations with the potential to differentiate into erythroid cells

Stem Cell Res Ther. 2021 Apr 13;12(1):236. doi: 10.1186/s13287-021-02311-y.

Abstract

Erythro-myeloid progenitors (EMP) are found in a population of cells expressing CD31 and CD45 markers (CD31+CD45+). A recent study indicated that EMPs persist until adulthood and can be a source of endothelial cells. We identified two sub-populations of EMP cells, CD31lowCD45low and CD31highCD45+, from peripheral blood that can differentiate into cells of erythroid lineage. Our novel findings add to the current knowledge of hematopoietic lineage commitment, and our sequential, dual-step, in vitro culture model provides a platform for the study of the molecular and cellular mechanisms underlying human hematopoiesis and erythroid differentiation.

Keywords: CD31+CD45+ circulating cells; Erythro-myeloid progenitors; Human erythropoiesis.

Publication types

  • Letter
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cell Differentiation
  • Endothelial Cells*
  • Erythroid Cells
  • Hematopoiesis
  • Hematopoietic System*
  • Humans